Biocompatibles UK Ltd / BTG Plc Follow / Connect - Business Profile & Social Media Wall / Press Room - Pharma / BioTech / Nutrition

Biocompatibles UK Ltd / BTG Plc Company Profile & Social Media Wall Press Room - Press Releases

Biocompatibles is a leading medical technology company in the field of drug device combination products. We operate through an Oncology Products Division and two R&D businesses (@BTG).

	Company Name:	Biocompatibles UK Ltd / BTG Plc
	Trading Symbol(s):	[LSE: BTG]
	Contact:	Press Office - BioCompatibles.com
	Address:	Confidential
	City:	Farnham
	Zip code:	GU9 8QL
	STATE / Prov.:	Surrey
	Country:	United Kingdom
	Primary Industry:	Pharma / BioTech / Nutrition
	PR Agency:	No

Your Company Advertising Here!
Showing along with this industry
- Learn more...

Latest Articles:
First Patient Treated with LC Bead LUMI™ Radiopaque Embolic Bead Supported by Philips Live Image Guidance - [ Pharma / BioTech / Nutrition ]
BTG Receives 510k Clearance for LC Bead LUMI™ - [ Pharma / BioTech / Nutrition ]
BTG Announces Positive Data from RENEW Study of PneumRx® Coils - [ Pharma / BioTech / Nutrition ]
BTG Announces FDA Approval of VISTOGARD® (Uridine Triacetate) as Antidote - [ Pharma / BioTech / Nutrition ]
BTG and MIRADA Collaborate to Develop Dosimetry Software Solutions to Optimise Radioembolisation Therapy in Interventional Oncology - [ Pharma / BioTech / Nutrition ]
BTG Announces FDA Acceptance of Wellstat Therapeutics’ New Drug Application for Uridine Triacetate - [ Pharma / BioTech / Nutrition ]
Health Canada Approves Varithena® (Polidocanol Injectable Foam) for Patients with Varicose Veins - [ Pharma / BioTech / Nutrition ]
First Patient in Singapore Treated with TheraSphere® Radioembolization Therapy - [ Pharma / BioTech / Nutrition ]
BTG Begins Sale of DC Bead® and Bead Block® Directly to Physicians - [ Pharma / BioTech / Nutrition ]
BTG to Supply DC Bead® and Bead Block® Directly to Physicians - [ Pharma / BioTech / Nutrition ]
BTG and SciClone Announce That DC Bead® Has Been Approved by China Food and Drug Administration - [ Pharma / BioTech / Nutrition ]
First Varicose Vein Patient Treated with FDA-Approved Varithena® (polidocanol injectable foam) 1% - [ Pharma / BioTech / Nutrition ]
BTG Participates in the Trekfest Challenge - [ Pharma / BioTech / Nutrition ]
Acute Pulmonary Embolism Trial Confirms Safety and Efficacy of Ultrasound Accelerated Endovascular Thrombolysis - [ Pharma / BioTech / Nutrition ]
BTG Announces Varithena™ Data Demonstrating Continued Improvement At One Year At The American Venous Forum Annual Meeting - [ Pharma / BioTech / Nutrition ]
Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association’s Journal - [ Pharma / BioTech / Nutrition ]
BTG’s Manufacturing Facility in West Wales Awarded Top Environmental Standard - [ Pharma / BioTech / Nutrition ]
BTG to Present At the 32nd Annual J.P. Morgan Healthcare Conference - [ Health / Surgery ]
BTG Plc - FDA Approves Varithena™ (polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins - [ Health / Surgery ]
BTG to Present at the Jefferies Global Healthcare Conference - [ Health / Surgery ]
BTG Sells Brachytherapy Business to Eckert & Ziegler - [ Pharma / BioTech / Nutrition ]
BTG plc - Positive Results from VANISH-2 Study Data Published in the Journal Phlebology - [ Pharma / BioTech / Nutrition ]
BTG plc Announces Completion of the Acqusition of TheraSphere® - [ Pharma / BioTech / Nutrition ]
BTG plc Acquisition of EKOS - [ Pharma / BioTech / Nutrition ]
Genzyme Receives Positive CHMP Opinion for LEMTRADA™ alemtuzumab in Europe - [ Pharma / BioTech / Nutrition ]

« Previous Page

Next Page »

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business

ó See your Ad Here! ó

PREMIUM Members

ó See your Logo Here! ó